Literature DB >> 16511647

Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study.

Andreas Fellgiebel1, Martin Mazanek, Catharina Whybra, Michael Beck, Ralf Hartung, Kay-Maria Müller, Armin Scheurich, Paulo R Dellani, Peter Stoeter, Matthias J Müller.   

Abstract

Fabry disease (FD) is a lysosomal storage disorder that is associated with marked cerebrovascular disease. Conventional MRI shows a progressive load of white matter lesions (WMLs) due to cerebral vasculopathy in the course of FD. To quantify brain structural changes in clinically affected male and female patients with FD we performed a prospective Diffusion-Tensor Imaging (DTI) study in 27 adult Fabry patients (13m, 14f) and 21 age-matched controls (12 m, 9f). Global Mean Diffusivity (MD) was increased in FD (P = 0.003) whereas global Fractional Anisotropy (FA) did not differ significantly between FD and controls. Even FD patients without significant WMLs (9m, 9f) showed increased global MD (P = 0.004). Regions of interest with significant MD elevations were located in the frontal, parietal and temporal white matter. No differences of thalamic and hippocampal DTI measurements could be detected between FD and controls. DTI parameters did not differ between male and female patients. The data provide the first evidence of a pattern of marked structural brain tissue alterations in adult FD male and female patients even without WMLs. DTI seems to be an appropriate diagnostic tool to quantify brain tissue integrity in FD. Moreover, this method could be favorable for longitudinal assessment of brain structure alterations in FD, and for monitoring the cerebral effects of enzyme replacement therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16511647     DOI: 10.1007/s00415-006-0118-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

2.  Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy.

Authors:  D F Moore; L T Scott; M T Gladwin; G Altarescu; C Kaneski; K Suzuki; M Pease-Fye; R Ferri; R O Brady; P Herscovitch; R Schiffmann
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

Review 3.  Anderson-Fabry disease: extrarenal, neurologic manifestations.

Authors:  Edwin H Kolodny; Gregory M Pastores
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

4.  White matter lesion severity in male and female patients with Fabry disease.

Authors:  A Fellgiebel; M J Müller; M Mazanek; K Baron; M Beck; P Stoeter
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

5.  Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study.

Authors:  Markus Holtmannspötter; Nils Peters; Christian Opherk; Daniel Martin; Jürgen Herzog; Hartmut Brückmann; Philipp Sämann; Andreas Gschwendtner; Martin Dichgans
Journal:  Stroke       Date:  2005-11-03       Impact factor: 7.914

6.  Fabry disease: fourteen alpha-galactosidase A mutations in unrelated families from the United Kingdom and other European countries.

Authors:  J P Davies; C M Eng; J A Hill; S Malcolm; K MacDermot; B Winchester; R J Desnick
Journal:  Eur J Hum Genet       Date:  1996       Impact factor: 4.246

7.  Selective arterial distribution of cerebral hyperperfusion in Fabry disease.

Authors:  D F Moore; P Herscovitch; R Schiffmann
Journal:  J Neuroimaging       Date:  2001-07       Impact factor: 2.486

8.  Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI.

Authors:  H Chabriat; S Pappata; C Poupon; C A Clark; K Vahedi; F Poupon; J F Mangin; M Pachot-Clouard; A Jobert; D Le Bihan; M G Bousser
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

9.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

Authors:  A Mehta; R Ricci; U Widmer; F Dehout; A Garcia de Lorenzo; C Kampmann; A Linhart; G Sunder-Plassmann; M Ries; M Beck
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

10.  Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study.

Authors:  M O'Sullivan; P E Summers; D K Jones; J M Jarosz; S C Williams; H S Markus
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

View more
  16 in total

1.  Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations.

Authors:  Sirio Cocozza; Giuseppe Pontillo; Mario Quarantelli; Francesco Saccà; Eleonora Riccio; Teresa Costabile; Gaia Olivo; Vincenzo Brescia Morra; Antonio Pisani; Arturo Brunetti; Enrico Tedeschi
Journal:  Hum Brain Mapp       Date:  2018-01-09       Impact factor: 5.038

2.  Diffusion tensor imaging and brain volumetry in Fabry disease patients.

Authors:  Teemu Paavilainen; Virva Lepomäki; Jani Saunavaara; Ronald Borra; Pirjo Nuutila; Ilkka Kantola; Riitta Parkkola
Journal:  Neuroradiology       Date:  2013-01-05       Impact factor: 2.804

3.  Brain white matter abnormalities in paediatric Gaucher Type I and Type III using diffusion tensor imaging.

Authors:  Elin Haf Davies; Kiran K Seunarine; Tina Banks; Chris A Clark; Ashok Vellodi
Journal:  J Inherit Metab Dis       Date:  2011-02-12       Impact factor: 4.982

4.  Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Authors:  Sirio Cocozza; Gaia Olivo; Eleonora Riccio; Camilla Russo; Giuseppe Pontillo; Lorenzo Ugga; Silvia Migliaccio; Dario de Rosa; Sandro Feriozzi; Massimiliano Veroux; Yuri Battaglia; Daniela Concolino; Federico Pieruzzi; Antonino Tuttolomondo; Aurelio Caronia; Cinzia Valeria Russo; Roberta Lanzillo; Vincenzo Brescia Morra; Massimo Imbriaco; Arturo Brunetti; Enrico Tedeschi; Antonio Pisani
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

5.  Detecting the effects of Fabry disease in the adult human brain with diffusion tensor imaging and fast bound-pool fraction imaging.

Authors:  Hunter R Underhill; Katie Golden-Grant; Lauren T Garrett; Stefanie Uhrich; Brandon A Zielinski; C Ronald Scott
Journal:  J Magn Reson Imaging       Date:  2015-05-27       Impact factor: 4.813

6.  The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease.

Authors:  Mario Tranfa; Mario Tortora; Giuseppe Pontillo; Valentina Iuzzolino; Eleonora Riccio; Simona Caccavallo; Teodolinda Di Risi; Serena Monti; Roberta Lanzillo; Vincenzo Brescia Morra; Giuseppe Palma; Maria Petracca; Antonio Pisani; Arturo Brunetti; Sirio Cocozza
Journal:  Eur Radiol       Date:  2022-01-14       Impact factor: 5.315

7.  The pulvinar sign: frequency and clinical correlations in Fabry disease.

Authors:  Alessandro P Burlina; Renzo Manara; Catherine Caillaud; Jean-Pierre Laissy; Mariasavina Severino; Isabelle Klein; Alberto Burlina; Olivier Lidove
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

8.  Voxel based analyses of diffusion tensor imaging in Fabry disease.

Authors:  J Albrecht; P R Dellani; M J Müller; I Schermuly; M Beck; P Stoeter; A Gerhard; A Fellgiebel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

9.  Redefining the Pulvinar Sign in Fabry Disease.

Authors:  S Cocozza; C Russo; A Pisani; G Olivo; E Riccio; A Cervo; G Pontillo; S Feriozzi; M Veroux; Y Battaglia; D Concolino; F Pieruzzi; R Mignani; P Borrelli; M Imbriaco; A Brunetti; E Tedeschi; G Palma
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-19       Impact factor: 3.825

Review 10.  Cognitive dysfunction and depression in Fabry disease: a systematic review.

Authors:  Fay E Bolsover; Elaine Murphy; Lisa Cipolotti; David J Werring; Robin H Lachmann
Journal:  J Inherit Metab Dis       Date:  2013-08-16       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.